ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

183
Analysis
Health Care • India
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets branded and generic formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company focuses on therapeutic areas including respiratory, dermatology, and oncology, with products such as Ryaltris, Winlevi, and Candid. It was founded in 1977 and is headquartered in Mumbai, India.
more
•31 Aug 2020 15:01

Asia HY Trade Recommendations - August 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of August includes a summary of our recommendations, as well as our high-conviction ideas....

Logo
370 Views
Share
•19 Aug 2020 16:15

Glenmark Pharmaceuticals - Earnings Flash - Q1 FY 2020-21 Results - Lucror Analytics

Glenmark Pharmaceuticals' Q1/20-21 results were better than expected, despite muted revenue growth amid the COVID-19 pandemic. The company...

Logo
337 Views
Share
bearish•PVR Inox
•08 Aug 2020 22:43

Forensic Accounting | High Risk Companies in India

As promised at Smartkarma Webinar | Accounting and Insider Diagnostics, we have extended our forensic analysis model to India. To learn more about...

Logo
642 Views
Share
•05 Aug 2020 15:54

Asia HY Monthly - LARA And Credit Bias Study (2020 Update) - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments for companies under our coverage over the past few years,...

Logo
518 Views
Share
bullish•Parkway Pantai Ltd
•03 Aug 2020 00:19

Parkway Pantai: Good Brand with Limited Upside

We initiate our coverage of Parkway Pantai Ltd (0794727D SP) (Parkway Pantai), a wholly-owned subsidiary of IHH Healthcare (IHH MK) of which major...

Logo
614 Views
Share
x